Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palivizumab for prevention of RSV burden and later wheeze in healthy preterm infants
2007-004105-10Phase 4Active
- Sponsor
- Wilhelmina Children's Hospital
- Start
- Jun 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of palivizumab in respiratory syncytial virus disease (RSV) (2 arms), sponsored by Wilhelmina Children's Hospital. Primary endpoint: Number of wheezing days during the first year of life. Started Jun 2008; status: active.
02
Drugs
palivizumab
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on 2007-004105-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004105-10.